Randomized Phase 2 Study of Erdafitinib vs Investigator Choice of Chemo in Subjects Who Received BCG and Recurred With HR NMIBC (42756493BLC2003)



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.